Neuroimaging Spectrum in COVID-19 Infection: A Single-Center Experience

Abstract Background and Purpose  The ongoing coronavirus disease 2019 (COVID-19) pandemic is a multisystemic disease and involvement of the nervous system is well established. The neurological and neuroimaging features of the disease have been extensively evaluated. Our study aimed to elucidate the neuroradiological findings in COVID-19 infected patients admitted to our institute during the first and second waves of the pandemic in India. Methods  This was a single-center retrospective study of all COVID-19 positive patients who underwent neuroimaging between March 2020 and May 2021. The presenting neurological complaints, the imaging findings in computed tomography (CT) imaging, and/or magnetic resonance imaging (MRI) were recorded. They recorded the findings in the subheadings of ischemic stroke, hemorrhagic stroke, parainfectious demyelination, acute encephalitis syndrome, and changes of global hypoxic changes. Patients with age-related, chronic, and incidental findings were excluded. Results  The study comprised of 180 COVID-19 positive patients who underwent neuroimaging. CT scan was performed for 169 patients, MRI for 28, and a combination of both CT and MRI was performed for 17 patients. Seventy percent of patients were males, and median age was 61.5 years (interquartile range: 48.25–70.75). Out of the 180 patients, 66 patients had nonspecific findings that could not be attributed to COVID-19 infection. In the remaining 114 patients, 77 (42.7%) had ischemic findings, while 22 (12.2%) had hemorrhagic stroke. Hypoxic ischemic changes were noted in five patients. The rest of the patients had a spectrum of changes including, cerebellitis (3), tumefactive demyelination (1), COVID-19-associated encephalitis (1), hemorrhagic acute demyelinating encephalomyelitis (1), transverse myelitis (1), cytotoxic lesions of corpus callosum (1), Guillain-Barre syndrome (1), and COVID-19-associated microhemorrhages (1). Conclusion  Neurological manifestations of COVID-19 infection are not uncommon, and our understanding of this topic is expanding. A complex interplay of neurotropism and direct central nervous system invasion, immune activation and cytokine storm, vasculitis, and parainfectious processes are implicated in the pathophysiology. While the most common imaging finding was ischemic stroke, followed by hemorrhagic stroke, a diverse range of parainfectious findings was also noted in our study.

[1]  Pratik V. Patel,et al.  Large Vessel Occlusions By Free Floating Thrombi in Strokes During the COVID-19 pandemic- A Single Center Observational Study , 2022, Neurology India.

[2]  J. Benito-León,et al.  Non-Aneurysmal Subarachnoid Hemorrhage in COVID-19: A Case Report and Review of Literature. , 2022, Medical research archives.

[3]  J. Bratosiewicz-Wąsik Neuro-COVID-19: an insidious virus in action. , 2021, Neurologia i neurochirurgia polska.

[4]  S. Misra,et al.  Frequency of Neurologic Manifestations in COVID-19 , 2021, Neurology.

[5]  Jichao Chen,et al.  SARS-CoV-2-associated acute disseminated encephalomyelitis: a systematic review of the literature , 2021, Journal of Neurology.

[6]  Amelia K. Adcock,et al.  Acute cerebellitis following SARS‐CoV‐2 infection: A case report and review of the literature , 2021, Journal of medical virology.

[7]  B. Kelley Tumefactive Acute Disseminated Encephalomyelitis after Recent Covid-19 Infection: A Case Report , 2021, Journal of Neurology Research Reviews & Reports.

[8]  G. Román,et al.  Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222) , 2021, Frontiers in Immunology.

[9]  A. Vaccaro,et al.  Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study , 2021, BMC Neurology.

[10]  H. Azevedo-Filho,et al.  Subarachnoid hemorrhage and COVID-19 , 2020, Medicine.

[11]  C. Filippi,et al.  The Spectrum of Neuroimaging findings on CT and MRI in Adults with Coronavirus Disease (COVID-19). , 2020, AJR. American journal of roentgenology.

[12]  M. Pandey,et al.  Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions , 2020, Neurological Sciences.

[13]  D. Annane,et al.  Teaching NeuroImages: Cytotoxic lesions of the corpus callosum in encephalopathic patients with COVID-19 , 2020, Neurology.

[14]  Matthew D. Li,et al.  Clinical and Neuroimaging Correlation in Patients with COVID-19 , 2020, American Journal of Neuroradiology.

[15]  Suzanne Harrogate,et al.  Non-aneurysmal subarachnoid haemorrhage in COVID-19 , 2020, Neuroradiology.

[16]  N. Gaspard,et al.  Cytotoxic lesions of the corpus callosum (CLOCCs) associated with SARS-CoV-2 infection , 2020, Journal of Neurology.

[17]  M. Lang,et al.  Paraspinal Myositis in Patients with COVID-19 Infection , 2020, American Journal of Neuroradiology.

[18]  K. Melmed,et al.  Cerebral Microbleeds and Leukoencephalopathy in Critically Ill Patients With COVID-19 , 2020, Stroke.

[19]  A. Akbari,et al.  A First Case of Acute Cerebellitis Associated with Coronavirus Disease (COVID-19): a Case Report and Literature Review , 2020, The Cerebellum.

[20]  J. Mocco,et al.  Association of Coronavirus Disease (COVID-19) With Large Vessel Occlusion Strokes: A Case-Control Study. , 2020, AJR. American journal of roentgenology.

[21]  S. Farhadian,et al.  Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. , 2020, JAMA neurology.

[22]  Zhi-qiang Zhou,et al.  Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms , 2020, Journal of Neurology.

[23]  Simon A. Jones,et al.  COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome , 2020, Journal of the Neurological Sciences.

[24]  J. Ruiz-Sandoval,et al.  Neurological manifestations of COVID-19. , 2020, Gaceta medica de Mexico.

[25]  A. Petridis,et al.  Letter to editor: Severe brain haemorrhage and concomitant COVID-19 Infection: A neurovascular complication of COVID-19 , 2020, Brain, Behavior, and Immunity.

[26]  Xiaosheng Wang,et al.  Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues , 2020, Infectious Diseases of Poverty.

[27]  Michael Roth,et al.  Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? , 2020, The Lancet Respiratory Medicine.

[28]  R. Rennert,et al.  Epidemiology, Natural History, and Clinical Presentation of Large Vessel Ischemic Stroke , 2019, Neurosurgery.

[29]  S. Lownie,et al.  Diagnosis and management of carotid free-floating thrombus: A systematic literature review , 2019, International journal of stroke : official journal of the International Stroke Society.

[30]  M. Templin,et al.  PLUMBER Study (Prevalence of Large Vessel Occlusion Strokes in Mecklenburg County Emergency Response) , 2017, Stroke.

[31]  J. Gornbein,et al.  Ischemic Strokes Due to Large-Vessel Occlusions Contribute Disproportionately to Stroke-Related Dependence and Death: A Review , 2017, Front. Neurol..

[32]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[33]  C. Moorehead All rights reserved , 1997 .

[34]  C. Dolea,et al.  World Health Organization , 1949, International Organization.